Aigen Investment Management »

Cytek Biosciences shares owned by Aigen Investment Management

Quarter-by-quarter ownership of Cytek Biosciences (CTKB) shares owned by Aigen Investment Management from 13F filings

Historical chart of Aigen Investment Management investment in Cytek Biosciences

Tip: Access up to 7 years of quarterly data

All positions including Cytek Biosciences held by Aigen Investment Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Cytek Biosciences by Aigen Investment Management

Quarter filed Position value Share count Share price at filing
2026-06-30 $62k 14k 4.43
2025-06-30 $50k 15k 3.40
2022-12-31 $144k 14k 10.21

More positions owned by Aigen Investment Management

Wells Fargo & Company (WFC)
Capital One Financial (COF)
CSX Corporation (CSX)
Abbott Laboratories (ABT)
Devon Energy Corporation (DVN)
PPL Corporation (PPL)
Gilead Sciences (GILD)
Taiwan Semiconductor Manufac Sponsored Ads (TSM)
Trane Technologies SHS (TT)
Chubb (CB)
Lockheed Martin Corporation (LMT)
Vertex Pharmaceuticals Incorporated (VRTX)
Flex Ord (FLEX)
Lpl Financial Holdings (LPLA)
3M Company (MMM)

View all positions for Aigen Investment Management

Top funds holding Cytek Biosciences

BlackRock
Millennium Management
Robeco Investment Management
Hillhouse Capital Advisors
Vanguard Capital Management
State Street Corporation
Geode Capital Management
Dimensional Fund Advisors
Goldman Sachs Group
Royce & Associates
Morgan Stanley
Russell Investments
Acadian Asset Management
Bank of America Corporation
Vanguard Portfolio Management

View all funds holding Cytek Biosciences